Introduction {#s1}
============

Skeletal muscle fibre formation requires a coordinated programme of morphological and biochemical changes in the differentiating cells. Upon differentiation, mono-nucleated myoblasts withdraw from the cell cycle and fuse to form syncytial myotubes ([@bib59]). The microtubule cytoskeleton is required for these processes ([@bib6]; [@bib26]; [@bib57]) and undergoes reorganisation into an array of paraxial microtubules ([@bib60]), which serves as template for contractile sarcomere formation ([@bib3]; [@bib43]).

During myogenesis, microtubules are rearranged from a dynamic radial array to a parallel array of stable posttranslationally modified microtubules within the elongating cell ([@bib60]; [@bib55]; [@bib47]; [@bib22]). Preventing detyrosination of tubulin or interfering with microtubule stabilisation by depletion of EB1 or MURF impairs expression of myogenic markers ([@bib49]; [@bib10]; [@bib64]), thus suggesting that signalling through modified microtubules might control myogenic differentiation. On the other hand, changes in the regulation of microtubule dynamics at the cell cortex that neither affect the content of tubulin modifications nor the expression of differentiation markers can result in cell polarisation and fusion defects as caused by the depletion of EB3 ([@bib52]). This suggests a dual function of microtubules during the early stages of muscle cell differentiation to control (1) morphological changes and (2) biochemical composition, before later serving as structural templates for myofibrillogenesis.

A number of microtubule-associated proteins (MAPs) have been implicated in the organisation of microtubules into bundles. MAP2 and tau determine the spacing between microtubules in dendrites and axons, but do not control the directionality of microtubules within those bundles ([@bib11]). Proteins of the PRC1/MAP65/Ase1 family preferentially bundle microtubules in antiparallel orientation and are responsible for the stabilisation of the antiparallel microtubule overlaps in the spindle midzone during mitosis ([@bib32]; [@bib18]; [@bib53]). Microtubule--microtubule sliding by Eg5, kinesin-1, kinesin-14, and dynein has been implicated in microtubule organisation and force generation ([@bib30]; [@bib15]; [@bib51]; [@bib8]; [@bib16]; [@bib33]; [@bib54]), and we begin to understand how the interplay of motors and MAPs organises particular microtubule arrangements ([@bib28]; [@bib5]; [@bib9]).

Here, we show that the microtubule array in myoblasts is highly motile and becomes increasingly parallelised and immobilised as cells progress through the differentiation programme. We identify a previously uncharacterised differentially regulated isoform of microtubule-associated protein MAP4, called oMAP4, as a key organiser of microtubules in differentiating cells. Depletion of oMAP4 results in microtubule misalignment and increased microtubule motility in differentiating muscle cells. This results in defects in myogenic progression, cell polarisation, and cell--cell fusion. We further show that oMAP4 zippers preferentially antiparallel microtubules in vitro and restricts motor-driven microtubule sliding in differentiating muscle cells. Based on our own data, we propose a model whereby the cooperation of motor-driven microtubule--microtubule sliding and oMAP4-mediated zippering organises the microtubule cytoskeleton in differentiating muscle cells to support and govern cell polarisation and differentiation.

Results {#s2}
=======

Microtubules become progressively more ordered and immobile during muscle differentiation {#s2-1}
-----------------------------------------------------------------------------------------

To characterise microtubule organisation in differentiating muscle cells, we determined filament orientation, motility, and growth characteristics of microtubules at different stages during differentiation of C2C12 cells. As reported previously, we found that microtubule organisation changes from a radial, centrosome-dominated array in undifferentiated cells, to a paraxial array in myotubes ([Figure 1A](#fig1){ref-type="fig"}) ([@bib60]; [@bib55]). Microtubule growth directionality relative to the longitudinal axis of the cell was determined by tracking EB3-tdTomato-labelled microtubule ends. The asymmetry in the distribution of microtubule growth angles increases significantly during the first two days of differentiation ([Figure 1B--D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). This suggests that guided growth of microtubules (probably along existing microtubules) contributes to the progressively more ordered parallel microtubule array in differentiating cells. Furthermore, microtubules within the array are highly motile in undifferentiated myoblasts as visualised by the photoactivation of paGFP-Tubulin or conversion of mEos2-Tubulin ([Figure 1E,F](#fig1){ref-type="fig"}, [Videos 1, 2](#video1 video2){ref-type="other"}). In differentiating muscle cells, microtubules become very stable and static as seen by the low frequency and speed of microtubule-sliding movements and by diminished loss of microtubules from the photoactivated region due to depolymerisation ([Figure 1E--H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}, [Video 3](#video3){ref-type="other"}). The reduction in microtubule movements could be due to the differential regulation of motors that drive microtubule sliding. Conventional kinesin as well as dynein has been implicated in microtubule--microtubule sliding and microtubule movement along the cell cortex in other cell systems ([@bib45]; [@bib15]; [@bib51]; [@bib4]; [@bib29]; [@bib48]; [@bib33]). Both motors contribute to microtubule movements in myoblasts as the frequency of microtubule movements was reduced more than threefold upon depletion of either dynein heavy chain or Kif5b ([Figure 1E--H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, [Videos 4, 5](#video4 video5){ref-type="other"}). However, Kif5b and dynein were continuously expressed during muscle differentiation ([Figure 1I](#fig1){ref-type="fig"}), suggesting that other factors prevent motor-dependent microtubule sliding and promote parallel microtubule array formation during myogenesis.10.7554/eLife.05697.003Figure 1.Microtubules are arranged in stable paraxial arrays during muscle cell differentiation.(**A**) Structured illumination microscopy of anti-tubulin-stained C2C12 cells pre/post induction of muscle differentiation as indicated. Microtubule filaments have been manually traced to highlight arrangement. Scale bar 10 μm. (**B**) Tracks of EB3-GFP in C2C12 cells at different stages of differentiation. Directionality is colour-coded (green and red: ±45° to longitudinal cell axis, blue and yellow: perpendicular to cell axis ±45°). Cell outlines are indicated with dashed white line. Scale bars 20 μm. (**C**) Cumulative distribution of MT growth angles for example cells shown in (**B**). Kuiper statistics (K--S) is calculated as a measure for microtubule alignment as the sum of the maximum deviations d1 and d2 from a random distribution. See [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} for angular histograms. (**D**) Average MT asymmetry of differentiating myoblasts. Data show mean ± SEM for 4--9 cells with \>5000 microtubule tracks per condition. (**E** and **F**) Motility of paGFP-Tubulin-labelled microtubule segments in myoblasts pre/post induction of differentiation and after depletion of dynein (shDHC) and kinesin-1 (shKHC). Bar-shaped patterns were activated perpendicular to the microtubule orientation using mCherry-Tubulin as marker (**F**). An individual bar-shaped activation pattern is shown in (**E**) for each condition. Arrows highlight microtubule-sliding events. Scale bars are 5 μm. See supplementary [Videos 1--5](#video1 video2 video3 video4 video5){ref-type="other"}. (**G** and **H**) Frequency and velocity of microtubule sliding events observed following photoactivation of tubulin segments. Data show mean ± SEM, n = 17--51 activated patterns. Asterisks indicate significant difference from undifferentiated control cells (\*p \< 0.05, \*\*p \< 0.005, \*\*\*p \< 0.0005). (**I**) Immunoblotting of C2C12 cell extracts pre/post induction of differentiation for DHC and KHC. Tubulin serves as loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.003](10.7554/eLife.05697.003)10.7554/eLife.05697.004Figure 1---figure supplement 1.Microtubule growth orientation.Angular distribution of microtubule growth data obtained from EB3-GFP tracks for the cells shown in [Figure 1B](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.004](10.7554/eLife.05697.004)10.7554/eLife.05697.005Figure 1---figure supplement 2.Dissipation of photoconverted microtubule labelling.Dissipation of photoconverted regions of mEos2-Tubulin in C2C12 cells before (undiff) and 48 hr post induction of differentiation. Cells were treated with Taxol to stop dissipation by depolymerisation, or azide to stop dissipation by motor-driven movement. Data have been corrected for bleaching by substraction of data from cells treated with both Taxol and azide. Data show mean ± SEM, n = 10--20 cells from two experiments. Half-life was determined from exponential decay curve fitted to the data.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.005](10.7554/eLife.05697.005)10.7554/eLife.05697.006Figure 1---figure supplement 3.Verification of dynein and kinesin depletion.Immunoblotting of C2C12 cell extracts from GFP-positive FACS-sorted cells treated with individual short hairpin RNAs (shRNAs) for 72 hr probed with antibodies as indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.006](10.7554/eLife.05697.006)Video 1.Photoconversion of mEos2-Tubulin in an undifferentiated C2C12 myoblast showing converted (left panel and magenta in right panel) and non-converted channels (middle panel and green in right panel).Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.007](10.7554/eLife.05697.007)10.7554/eLife.05697.007Video 2.Photoactivation of bar-shaped patterns of paGFP-Tubulin in an undifferentiated C2C12 myoblast.Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.008](10.7554/eLife.05697.008)10.7554/eLife.05697.008Video 3.Photoactivation of bar-shaped patterns of paGFP-Tubulin in a 94-hr differentiated C2C12 myoblast.Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.009](10.7554/eLife.05697.009)10.7554/eLife.05697.009Video 4.Photoactivation of bar-shaped patterns of paGFP-Tubulin in an undifferentiated C2C12 myoblast treated with shRNA against dynein heavy chain.Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.010](10.7554/eLife.05697.010)10.7554/eLife.05697.010Video 5.Photoactivation of bar-shaped patterns of paGFP-Tubulin in an undifferentiated C2C12 myoblast treated with shRNA against kinesin heavy chain (Kif5b).Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.011](10.7554/eLife.05697.011)10.7554/eLife.05697.011

Three MAP4 isoforms are expressed in differentiating muscle cells {#s2-2}
-----------------------------------------------------------------

Structural MAPs are candidates for a role in organising parallel microtubule arrays and regulating motor activity. MAP4, the only non-neuronal member of the MAP2/Tau family, has been reported to stabilise and bundle microtubules ([@bib2]; [@bib62]; [@bib42]; [@bib38], [@bib39]; [@bib23]). Our previous finding that MAP4 can limit force generation by dynein motors ([@bib48]) suggested that MAP4 might prevent dynein-driven microtubule motility in muscle cells. Mouse skeletal muscle cells express tissue-specific isoforms of MAP4 ([@bib34]). To investigate the differential regulation of experimentally confirmed and predicted MAP4 transcripts ([Figure 2A](#fig2){ref-type="fig"}), we performed RT-PCR analysis of total RNA isolated from differentiating C2C12 cells. We confirmed the continuous expression of the ubiquitous isoform uMAP4 and upregulation of muscle-specific mMAP4 24 hr post induction of differentiation ([Figure 2B](#fig2){ref-type="fig"}). Interestingly, we found that a previously uncharacterised isoform, with a unique 48 kD projection domain, was also upregulated after 24 hr of differentiation. In addition to muscle, this isoform is also highly expressed in brain tissue ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). We refer to this isoform as oMAP4. Further analysis revealed that uMAP4, mMAP4, and oMAP4 transcripts were each expressed as variants with three, four, or five tau-like microtubule binding repeats due to alternative splicing of exons 14 and 15 ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). To confirm that these transcripts encode proteins, we generated specific antibodies for mMAP4 and oMAP4 and probed whole cell lysates of C2C12 cells on Western blots. Both mMAP4 and oMAP4 protein levels increase between 24 and 48 hr after differentiation ([Figure 2C,D](#fig2){ref-type="fig"}). As expected, GFP-fusion proteins of uMAP4, mMAP4, and oMAP4 decorated microtubules along their length in C2C12 cells ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).10.7554/eLife.05697.012Figure 2.oMAP4 is required for myoblast elongation and fusion.(**A**) Domain organization of MAP4 isoforms. Green and red boxes represent isoform-specific regions in the projection domains of mMAP4 and oMAP4, respectively. Note that all three isoforms are expressed with 3, 4, or 5 tau-like MT binding repeats. (**B**) RT-PCR-based MAP4 expression analysis of RNA samples isolated from 0--60 hr differentiated C2C12 cells. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as loading control. (**C** and **D**) Immunoblotting of extracts from 0 to 96 hr differentiated C2C12 cells using antibodies against the N-terminus of oMAP4 (**C**) or the muscle-specific insertion of mMAP4 (**D**). Tubulin was used as a loading control. (**E**) Examples of shRNA-treated cells co-expressing GFP-Tubulin 48 hr after induction of differentiation. Scale bar 50 μm. (**F**, **H**) Distribution of cell lengths after 48 hr differentiation following treatment with indicated shRNAs. 1000--1900 cells were measured from three independent experiments for each condition. Small triangles represent mean values. (**G**, **I**) Myoblast fusion analyses of C2C12 cells treated with indicated shRNAs after 56 hr differentiation.1000--1200 cells were analysed for each condition and only cells with three or more nuclei were scored as fused. Data are collected from three experiments for each condition and are presented as mean ± S.E.M. Asterisks indicate significant difference from shControl treatment or between pairs of samples as indicated (\*p \< 0.05, \*\*p \< 0.005, \*\*\*p \< 0.0005).**DOI:** [http://dx.doi.org/10.7554/eLife.05697.012](10.7554/eLife.05697.012)10.7554/eLife.05697.013Figure 2---figure supplement 1.Expression of major MAP4 isoforms.Relative transcript abundances of MAP4 isoforms during myoblast differentiation as determined by analysis of RNA sequencing data from undifferentiated and 60 hr differentiated C2C12 cells ([@bib58]). Comparative expression levels of MAP4 isoforms in several mouse tissues obtained by analysis of Affymetrix exon array data ([@bib44]). Data are shown as mean ± SD from three experiments for each tissue. See previously generated data sets 1--2 in supplement.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.013](10.7554/eLife.05697.013)10.7554/eLife.05697.014Figure 2---figure supplement 2.C2C12 cells express three major MAP4 isoforms with variable numbers of MT binding repeats.RT-PCR from total RNA isolated from C2C12 cells before (0 hr) and 48 hr post induction of differentiation with upstream primers specific for projection domains of uMAP4, mMAP4, and oMAP4 and downstream primer at 3′ end of the MAP4 coding sequence to determine number of microtubule binding repeats. Digestion of PCR from 48 hr differentiated cells with exon-specific restriction nucleases to determine spliced exons that give rise to variants with different numbers of microtubule binding repeats.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.014](10.7554/eLife.05697.014)10.7554/eLife.05697.015Figure 2---figure supplement 3.Microtubular localisation of eGFP-tagged MAP4 isoforms in C2C12 cells.Tubulin is used as a marker for microtubules. Scale bars are 20 μm, insets 2 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.015](10.7554/eLife.05697.015)10.7554/eLife.05697.016Figure 2---figure supplement 4.Verification of mMAP4 depletion by immunofluorescence.Protein depletion was quantified by counting cells that expressed mMAP4 in GFP-Tubulin and shRNA co-expressing cells. Bars are 20 μm. 40--50 cells each were analysed for shControl and sh-mMAP4 transfections.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.016](10.7554/eLife.05697.016)10.7554/eLife.05697.017Figure 2---figure supplement 5.Verification of MAP4 depletion by immunoblotting.Immunoblotting of C2C12 cell extracts treated with individual shRNAs as indicated for 70--74 hr. Tubulin serves as loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.017](10.7554/eLife.05697.017)10.7554/eLife.05697.018Figure 2---figure supplement 6.Verification of oMAP4 depletion and RNAi-protected rescue construct by immunoblotting.Immunoblot of whole cell extracts of HeLa cells co-transfected with shRNAs and control or rescue plasmids. Tubulin serves as loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.018](10.7554/eLife.05697.018)

oMAP4 is required for muscle cell elongation and fusion {#s2-3}
-------------------------------------------------------

To investigate their involvement in microtubule organisation in muscle cells, we depleted each MAP4 isoform using a vector-based RNA interference approach. GFP-Tubulin was co-expressed with the short hairpin RNAs (shRNAs) to serve as a marker to detect successful transfection. Efficient depletion was confirmed by Western blotting of FACS-sorted GFP-positive cells and by immunofluorescence ([Figure 2---figure supplements 4, 5](#fig2s4 fig2s5){ref-type="fig"}). Muscle differentiation phenotypes were assessed as (1) the ability of single nucleated cells to elongate and (2) the efficiency of cells to fuse and form syncytia containing three or more nuclei ([@bib52]). 48 hr after differentiation, the average length of myoblasts treated with control shRNA was 107 ± 40 μm. Depletion of uMAP4 did not significantly affect this (105 ± 36 μm, p = 0.4; [Figure 2E,F](#fig2){ref-type="fig"}). Depletion of mMAP4 allowed myoblasts to elongate to an average length of 143 ± 58 μm, which is significantly longer than control cells. Myoblast fusion efficiency was not significantly affected following the depletion of uMAP4 or mMAP4 ([Figure 2G](#fig2){ref-type="fig"}). In contrast, the depletion of oMAP4 caused severe defects in myoblast elongation and fusion. oMAP4-depleted cells had an average length of 82 ± 39 μm, which is significantly shorter than control myoblasts (p \<\< 0.001, [Figure 2E,F](#fig2){ref-type="fig"}). Furthermore, cell--cell fusion efficiency was reduced more than fourfold following depletion of oMAP4 ([Figure 2G](#fig2){ref-type="fig"}). Importantly, co-transfection of an RNAi-resistant version of oMAP4 (FLAG-oMAP4^RIP^) rescued the myoblast elongation and fusion defects caused by oMAP4 shRNA ([Figure 2H,I](#fig2){ref-type="fig"}, [Figure 2---figure supplement 6](#fig2s6){ref-type="fig"}). The overexpression of uMAP4 was not able to rescue oMAP4-depletion phenotypes ([Figure 2I](#fig2){ref-type="fig"}). Our data collectively demonstrate that oMAP4 is specifically required for morphogenesis and cell--cell fusion during muscle cell differentiation.

oMAP4 depletion leads to disorganised microtubules {#s2-4}
--------------------------------------------------

To understand which processes in the myogenic programme depend on oMAP4, we analysed the timing of myogenic events. We find a severe delay and reduction in the expression of embryonic myosin, a structural protein required for sarcomere formation, in oMAP4-depleted cells ([Figure 3A--C](#fig3){ref-type="fig"}). Likewise, the relocation of centrosomal proteins to the nuclear surface of myoblasts, a characteristic event during myogenesis ([@bib55]; [@bib50]), is severely delayed in oMAP4-depleted cells ([Figure 3D,E](#fig3){ref-type="fig"}). These results confirm that progression through the myogenic differentiation programme depends on oMAP4. Previous work has shown that interference with microtubule stability and the acquisition of posttranslational modifications of tubulin result in similar myogenesis defects ([@bib49]; [@bib10]; [@bib64]). Depletion of oMAP4 did not result in a reduction of tubulin acetylation ([Figure 3F](#fig3){ref-type="fig"}), perhaps because other microtubule stabilisers were still present. Nevertheless, the microtubule cytoskeleton appeared disorganised in oMAP4-depleted cells ([Figure 3A,B](#fig3){ref-type="fig"}). To quantitatively assess microtubule network organisation and distinguish this from effects due to different morphology and differentiation status, we selected mono-nucleated elongated myoblasts treated with control and oMAP4 shRNA and manually traced GFP-Tubulin-labelled microtubules in equivalent sections of these cells ([Figure 3G](#fig3){ref-type="fig"}, [Videos 6, 7](#video6 video7){ref-type="other"}). We found that the microtubule network was largely parallel in control cells with ∼80% of microtubules oriented ±15° of the longitudinal cell axis. This was reduced to ∼50% in oMAP4-depleted cells ([Figure 3H](#fig3){ref-type="fig"}). Microtubule orientation was fully rescued by expression of an RNAi-resistant oMAP4 construct ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Depletion of mMAP4 increased paraxial microtubule alignment and uMAP4 depletion slightly reduced it ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). We confirmed the microtubule alignment defect caused by oMAP4 depletion results by tracking growing microtubule ends labelled with EB3-tdTomato ([Figure 3I](#fig3){ref-type="fig"}, [Videos 8, 9](#video8 video9){ref-type="other"}). While microtubule growth speed and duration were only slightly affected, the orientation of microtubule growth deviated more from the longitudinal cell axis when oMAP4 was depleted compared to control cells ([Figure 3J--L](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).10.7554/eLife.05697.019Figure 3.oMAP4 is required for the parallel arrangement of microtubules in differentiating muscle cells.(**A** and **B**) C2C12 myoblasts 48 hr after induction of differentiation treated with shRNA as indicated and stained for Myogenin (a marker for differentiating myoblasts, yellow), PCM-1 (red) and DAPI (blue). GFP-Tubulin (green) indicates successful transfection with shRNA. Insets show higher magnification of microtubule arrangement. Scale bars 25 μm, 5 μm in insets. (**C**) Timecourse of expression of embryonic myosin, a marker of myogenic differentiation. (**D**) Timecourse of relocalisation of PCM-1 from a focus around the centrosome to the surface of the nucleus. Cells with a complete nuclear ring were scored as positive. Data in **C**, **D** show mean ± SD, n = 30--50 cells from 2 experiments. (**E**) RNAi rescue experiment of delayed PCM-1 relocalisation phenotype. Data show mean ± SEM of 3 experiments with 50--60 cells each. (**F**) Timecourse of accumulation of cells with acetylated tubulin during muscle cell differentiation. Data in show mean ± SD, n = 30--50 cells from 2 experiments. (**G**) Manual tracing of microtubule filaments (yellow) relative to the longitudinal cell axis (red) in elongated mono-nucleated cells selected after 48 hr differentiation and shRNA treatment as indicated. Scale bars 10 μm. See supplementary [Videos 6, 7](#video6 video7){ref-type="other"}. (**H**) Microtubule directionally from data as in g shown as cummulative frequency distribution. Data show mean ± SD, n = 3 experiments, 1522--1958 MTs. (**I**) Automatic tracking of EB3-tdTomato comets in elongated mono-nucleated cells selected after 48 hr differentiation and shRNA treatment as indicated. Direct lines from start to end of track are shown and colour-coded for direction relative to longitudinal axis of cell as indicated in legend. Scale bars 10 μm. See supplementary [Videos 8, 9](#video8 video9){ref-type="other"}. (**J**) Distribution of microtubule growth angles obtained from data as in **H**. Data show mean ± SD, n = 3 experiments, 6251--6382 tracks. (**K** and **L**) Microtubule growth speed and duration was determined from EB tracks as in **I**. Pooled data shown as statistical box plots with percentiles as indicated.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.019](10.7554/eLife.05697.019)10.7554/eLife.05697.020Figure 3---figure supplement 1.Microtubule orientation in depleted cells.Manual segmentation of microtubules (white/black), their angular distribution relative to main cell axis (red), and cumulative frequency of microtubule orientation following depletion of individual MAP4 isoforms and in oMAP4 RNAi rescue experiment. n ≥ 10 cells. Kuiper statistic relative to random distribution is calculated as in [Figure 1C](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.020](10.7554/eLife.05697.020)10.7554/eLife.05697.021Figure 3---figure supplement 2.Microtubule growth orientation in depleted cells.Angular distribution of microtubule growth data from [Figure 3J](#fig3){ref-type="fig"}. To aid visualisation of data tails, bin size increases progressively between 0 and ±60° and is then constantly 30°.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.021](10.7554/eLife.05697.021)Video 6.Microtubule orientation in a 48 hr differentiated C2C12 myoblast treated with shControl co-expressing GFP-Tubulin.Manual tracing of microtubule cytoskeleton (yellow lines) and main cell axis (red line) shown as used for analysis. Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.022](10.7554/eLife.05697.022)10.7554/eLife.05697.022Video 7.Microtubule orientation in a 48-hr differentiated C2C12 myoblast treated with sh-oMAP4 co-expressing GFP-Tubulin.Manual tracing of microtubule cytoskeleton (yellow lines) and main cell axis (red line) shown as used for analysis. Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.023](10.7554/eLife.05697.023)10.7554/eLife.05697.023Video 8.Growing microtubules in a 48-hr differentiated C2C12 myoblast treated with sh-Control co-expressing EB3-tdTomato.Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.024](10.7554/eLife.05697.024)10.7554/eLife.05697.024Video 9.Growing microtubules in a 48-hr differentiated C2C12 myoblast treated with sh-oMAP4 co-expressing EB3-tdTomato.Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.025](10.7554/eLife.05697.025)10.7554/eLife.05697.025

oMAP4 prevents motor-driven microtubule sliding in cells {#s2-5}
--------------------------------------------------------

We hypothesised that a failure in the guidance of microtubule assembly along existing filaments could be the underlying cause of the disorganised microtubule network. Alternatively, microtubule sliding and looping as observed in undifferentiated cells could disorganise the microtubule network in oMAP4-depleted cells. To distinguish between these possibilities, we analysed microtubule motility in differentiated, shRNA-treated cells, again selecting elongated, mono-nucleated cells to exclude effects due to morphology alone. As described above, microtubule motility was strongly suppressed in differentiating muscle cells ([Figures 1E--H, 4a](#fig1 fig4){ref-type="fig"}). Depletion of oMAP4 resulted in a more than fourfold increase in the frequency of microtubule sliding events, and these were significantly faster than those in control cells ([Figure 4A--D](#fig4){ref-type="fig"}). In addition, the rare sliding events in differentiated control cells were usually restricted to movements parallel to the long axis of the cell, while microtubules were observed to loop in oMAP4-depleted cells, similarly to undifferentiated cells ([Figure 4E](#fig4){ref-type="fig"}, [Videos 1--3, 10, 11](#video1 video2 video3 video10 video11){ref-type="other"}). These observations suggest that oMAP4 acts to maintain the parallel microtubule network by restricting microtubule movement, especially those that are off-axis.10.7554/eLife.05697.026Figure 4.oMAP4 prevents microtubule sliding in cells.(**A**) Microtubule motility (arrows) observed after photoconversion of mEOS2-Tubulin in 48 hr differentiated cells treated with shRNA as indicated. Scale bars 5 μm. See supplementary [Videos 10, 11](#video10 video11){ref-type="other"}. (**B**) Frequency of microtubule motility events relative to average sliding velocity in 48-hr differentiated cells treated with shRNA as indicated. Data pooled from three experiments, n = 15--23 cells. (**C** and **D**) Frequency of microtubule motility events: all events are shown in **C**, while only fast sliding events are shown in **D**. The latter were defined as movement faster than 700 nm/s. Data show mean ± SD, n = 3 experiments, 15--23 cells. (**E**) Directionality of microtubule motility events. Paraxial movement is defined as occurring parallel to the long cell axis with a deviation less than 45°. Looping microtubules changed direction by more than 90° during the movement event. Data show mean ± SD, n = 3 experiments, 15--23 cells. (**F** and **G**) Expression of GFP-oMAP4 (upper row) or GFP-uMAP4 (lower row) in undifferentiated C2C12 cells stained with tubulin antibodies. The number of strong microtubule bundles (arrows) of at least 2-μm length and threefold intensity of an individual microtubule was scored. Data in g show mean ± SEM, n = 13--23 cells. oMAP4 causes statistically significant change (p = 0.02). Scale bar 20 μm, 2 μm in insets.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.026](10.7554/eLife.05697.026)10.7554/eLife.05697.027Figure 4---figure supplement 1.Microtubule orientation in depleted cells.Examples of microtubule traces (yellow) in dynein depleted and dynein + oMAP4-depleted 48 hr differentiated elongated myoblasts, see [Figure 3G](#fig3){ref-type="fig"} for examples for control and oMAP4 depletion. Angular distribution and cumulative frequency of microtubule orientation relative to the main cell axis (red) is shown for data pooled from three experiments. Kuiper statistic relative to random distribution is calculated as in [Figure 1C](#fig1){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.027](10.7554/eLife.05697.027)Video 10.Photoconversion of bar-shaped patterns of mEOS2-Tubulin in a 48-hr differentiated C2C12 myoblast treated with shControl.Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.028](10.7554/eLife.05697.028)10.7554/eLife.05697.028Video 11.Photoconversion of bar-shaped patterns of mEOS2-Tubulin in a 48-hr differentiated C2C12 myoblast treated with sh-oMAP4.Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.029](10.7554/eLife.05697.029)10.7554/eLife.05697.029

As we demonstrated in a previous study that uMAP4 limits force generation by dynein to prevent excessive movement of astral microtubules along the cell cortex ([@bib48]), we wondered whether oMAP4 prevents microtubule sliding by inhibiting dynein function directly or whether oMAP4 crosslinks microtubules and acts as a brake to all motor-driven sliding. In order to distinguish between these possibilities, we co-depleted dynein from oMAP4-depleted cells. If oMAP4 would act exclusively through dynein, we posited this should rescue the depletion phenotypes. Depletion of dynein heavy chain alone did not significantly affect the already low-microtubule sliding frequencies in differentiated cells, although the velocity of microtubule sliding was reduced ([Figure 4B--D](#fig4){ref-type="fig"}). Cells co-depleted for dynein and oMAP4 still showed a high frequency of microtubule-sliding events ([Figure 4B,C](#fig4){ref-type="fig"}), although fast sliding events and looping were reduced ([Figure 4D,E](#fig4){ref-type="fig"}). Consequently, dynein co-depletion slightly alleviated the microtubule disorganisation caused by oMAP4 depletion, but did not fully rescue it ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). These results suggest that oMAP4 prevents microtubule sliding by crosslinking microtubules rather than by inhibiting dynein force generation per se. Indeed, expression of GFP-oMAP4 in undifferentiated myoblasts resulted in a significant increase in strong microtubule bundles, while expression of GFP-uMAP4 had no effect ([Figure 4F,G](#fig4){ref-type="fig"}).

oMAP4 crosslinks antiparallel microtubules in vitro {#s2-6}
---------------------------------------------------

To directly test the hypothesis that oMAP4 is a crosslinker, we recombinantly expressed and purified oMAP4 and GFP-oMAP4 from *Escherichia coli* ([Figure 5A](#fig5){ref-type="fig"}). Using in vitro microtubule co-sedimentation assays, we confirmed microtubule-binding activity of the purified proteins ([Figure 5B](#fig5){ref-type="fig"}). When Taxol- or GMP-CPP-stabilised microtubules were incubated with 60-nM oMAP4, we frequently observed microtubule bundles and structures with crossovers ([Figure 5C--F](#fig5){ref-type="fig"}). This confirmed that oMAP4 has microtubule cross-linking activity. We next asked whether oMAP4 has the ability to organise dynamic microtubules into antiparallel bundles in vitro. To do this, we used total internal reflection (TIRF) microscopy to visualise microtubules assembled from biotinylated microtubule seeds immobilised on streptavidin-coated coverslips. In control chambers, microtubules continued growing without changing direction when they encountered other microtubules and microtubules only overlapped when they happened to grow in the same direction ([Figure 6A,B](#fig6){ref-type="fig"}, [Video 12](#video12){ref-type="other"}). The addition of GFP-oMAP4 promoted zippering of those growing microtubules that encountered each other at shallow angles ([Figure 6A--C](#fig6){ref-type="fig"}; [Video 13](#video13){ref-type="other"}). To assess whether oMAP4 was specific for the orientation of the microtubules, we determined microtubule polarity based on the growth characteristics of the microtubule ends observed in the video ([Figure 6C](#fig6){ref-type="fig"}) and determined the rate of microtubule zippering relative to the incident angle of the two microtubules. No microtubule-zippering events were observed at angles between 25° and 150°, suggesting that oMAP4 can only generate forces to bend microtubules by up to 30°. Furthermore, oMAP4 showed a strong preference for zippering antiparallel-oriented microtubules ([Figure 6B,C](#fig6){ref-type="fig"}).10.7554/eLife.05697.030Figure 5.oMAP4 bundles microtubules in vitro.(**A**) SDS-PAGE analysis of oMAP4 protein purification. N-terminally 6xHis tagged full-length oMAP4 was purified by Ni^2+^-NTA affinity chromatography followed by ion exchange chromatography. (**B**) Microtubule co-sedimentation analysis of oMAP4 protein. Purified protein from (**A**) was incubated with Taxol-stabilised microtubules prior to centrifugation. Separate centrifugations of microtubules alone and oMAP4 protein alone were used as controls. Pellet and supernatant fractions were analysed by SDS-PAGE and Coomassie staining. (**C** and **D**) Analysis of microtubule bundling by oMAP4 in vitro. Taxol- or GMP-CPP-stabilised microtubules were incubated with buffer or 60 nM purified oMAP4 protein before spreading on glass for imaging. Insets show various microtubule crosslinking and bundling events. Scale bars 20 μm, 5 μm in insets. (**E** and **F**) Comparison of bundling efficiency of oMAP4 with negative control (EB1) and positive control (PRC1). Representative image and data quantified from \>300 microtubules are shown. Scale bar 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.030](10.7554/eLife.05697.030)10.7554/eLife.05697.031Figure 6.oMAP4 zippers dynamic microtubules with a bias for antiparallel arrangements.(**A**) Dynamic Rhodamine-labelled microtubules (greyscale) assembled from immobilised Hilyte640-labelled seeds (red) in vitro are zippered in the presence of oMAP4. Arrows highlight bundled microtubules. Scale bar 10 μm. (**B**) Histogram showing proportion of microtubule encounters leading to MT zippering relative to microtubule encounter angles. Antiparallel encounters are observed at angles above 90°. Note no zippering occurs between 25 and 150°. Data for GFP-oMAP4, EB1-GFP and PRC1, each at 80 nM concentration are shown for comparison. n ≥ 400 microtubule encounters for control and oMAP4, 136 encounters for PRC1 and 184 encounters for EB1. (**C**) Example of zippering events (arrows) in the presence of 80 nM oMAP4-GFP. Microtubule polarity is indicated with (+) at the dynamic plus end. See supplementary [Videos 12, 13](#video12 video13){ref-type="other"}. Scale bar 10 μm. (**D** and **E**) Immunoblot of oMAP4 in fractions from glycerol gradients to determine its sedimentation coefficient with volume from top of gradient indicated (**D**). Calibration curve using standard proteins with known sedimentation coefficients and linear regression curve (**E**).**DOI:** [http://dx.doi.org/10.7554/eLife.05697.031](10.7554/eLife.05697.031)10.7554/eLife.05697.032Figure 6---figure supplement 1.Microtubule length distribution in zippering experiments.For microtubule encounters between 10 and 30° incident angle in (near) parallel or (near) antiparallel orientation, the length of each microtubule was measured to the attached seed or the closest crossover point. None of the distributions are significantly different. n = 22--54 encounters.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.032](10.7554/eLife.05697.032)Video 12.TIRF-based assay showing dynamic Rhodamine-labelled microtubules assembled from immobilised seeds.Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.033](10.7554/eLife.05697.033)10.7554/eLife.05697.033Video 13.TIRF-based assay showing dynamic microtubules in the presence of 80 nM GFP-oMAP4.Note that antiparallel microtubule encounters result in zippering into an antiparallel bundle in most cases. Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.034](10.7554/eLife.05697.034)10.7554/eLife.05697.034

Another known antiparallel microtubule-bundling protein, PRC1 is a dimer that accumulates specifically in antiparallel-microtubule overlaps in the spindle midzone ([@bib53]). We observed that PRC1 was more potent to bundle-stabilised microtubules free in solution than oMAP4 ([Figure 5E,F](#fig5){ref-type="fig"}). However, PRC1 was not able to zipper microtubules in our assays using dynamic microtubules growing from immobilised seeds ([Figure 6B](#fig6){ref-type="fig"}). This is in agreement with the literature that described PRC1 to specifically bind to antiparallel-microtubule overlaps that form when microtubules 'occasionally encountered each other in a plus end-to-plus end configuration' ([@bib5]) rather than PRC1 itself causing the formation of the overlaps. We do not observe a substantial enrichment of GFP-oMAP4 in antiparallel or parallel overlaps ([Figure 6C](#fig6){ref-type="fig"}). To determine whether the bias in zippering towards antiparallel-oriented microtubules could be due to differences in the length of microtubules that encountered each other, we measured the length dependence of MAP4-mediated zippering. We found similar distributions of microtubule lengths for encounters that resulted in zippering and those encounters that occurred at similarly shallow-incipient angles but not led to zippering (p = 0.22). Likewise, there was no difference between parallel and antiparallel encounters that were zippered (p = 0.59) and those that did not result in zippering (p = 0.88) ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Therefore, our results demonstrate that oMAP4 is a microtubule-organising factor, which can arrange microtubules into antiparallel and with lesser efficiency parallel bundles. This function is consistent with the depletion phenotypes observed in differentiating muscle cells, where oMAP4 helps to arrange paraxial microtubules and thereby supports cell differentiation.

oMAP4 bundles withstand motor forces {#s2-7}
------------------------------------

PRC-1 is dimer that forms highly ordered crosslinks that do not substantially limit microtubule--microtubule sliding at moderate concentrations ([@bib53]). As we proposed that oMAP4 contributes to microtubule alignment by preventing microtubule sliding in differentiating muscle cells, we next asked how oMAP4-crosslinks microtubules and whether these can withstand motor forces. We considered whether the unique projection domain in oMAP4 confers microtubule cross-linking activity by dimerisation. Proteins of the MAP2/tau family are highly elongated, structurally disordered monomers ([@bib25]; [@bib13]). Using the GOR secondary structure prediction method, we find that oMAP4, uMAP4, and tau share a similar structure of over 60% random coil, about 20% helical, and 13% extended strand ([@bib19]). Furthermore, no significant coiled-coil domain was predicted. To confirm this, we performed sedimentation analysis of bacterially expressed oMAP4 and GFP-oMAP4 in comparison with a number of standard proteins ([Figure 6D,E](#fig6){ref-type="fig"}). We obtained sedimentation constants of 3.6 ± 0.25 S and 4.3 ± 0.21 S, respectively. Given the molecular weight of the monomers being 99 kD and 131 kD, respectively, we can calculate the frictional ratio *ƒ/ƒ*~min~ = 2.1, suggesting that oMAP4 is a highly elongated monomer with a shape comparable to tau (*ƒ/ƒ*~min~ = 1.8, \[[@bib13]\]). We, therefore, predict that oMAP4 most likely bundles microtubules using a second microtubule-binding region in its projection domain.

Single kinesin-1 and dynein molecules can generate forces of up to 7 pN ([@bib40]; [@bib56]). To determine whether oMAP4 bundling can indeed withstand the forces exerted by several motors tugging the microtubules apart, we performed gliding assays with kinesin-1. The presence of 80 nM oMAP4 did only slightly affect the velocity of kinesin-mediated movements of single microtubules ([Figure 7A,B](#fig7){ref-type="fig"}). However, antiparallel-microtubule bundles formed in solution and landing on the kinesin surface were often static or their movement was slow and non-persistent ([Figure 7C--E](#fig7){ref-type="fig"}, [Video 14](#video14){ref-type="other"}). Given their predominantly antiparallel arrangement, forces on the microtubules within a bundle would cancel each other out as long as the linkage between the microtubules is maintained. Occasionally, bundles were driven apart. This usually occurred in bundles where extensive lateral forces were generated on one microtubule that was significantly longer than other microtubules in the bundle ([Figure 7C](#fig7){ref-type="fig"}). The antiparallel nature of the oMAP4-generated bundles was confirmed in these cases from the opposing direction of their movement after separation ([Figure 7C](#fig7){ref-type="fig"}, magenta arrows). Most importantly, we observed that more than 75% of microtubule bundles withstand motor forces for the entire duration of our 7.5 min videos ([Figure 7C,E,F](#fig7){ref-type="fig"}, yellow arrows), suggesting that oMAP4-mediated cross-linking is indeed able to prevent motor-driven microtubule sliding as we hypothesised.10.7554/eLife.05697.035Figure 7.oMAP4 bundles can withstand motor forces.(**A**) Microtubule gliding assay on a Drosophila kinesin-1-coated surface. Time colour-coded projections over 30 s are shown for buffer control and 80 nM oMAP4. (**B**) Instantaneous speeds of microtubule motility were determined from tracks of 50 microtubules and shown as histograms. The presence of 80 nM oMAP4 reduces velocity of single microtubules by about 5%. (**C**) Microtubule bundles formed in solution by oMAP4 and landing on the kinesin-coated surface tend not to move (yellow filled arrows), while single microtubules do (green arrows). In about 25% of cases, bundles are driven apart by motor forces (magenta filled arrows) with microtubules gliding apart at normal speed once separated (magenta arrows). See supplementary [Video 14](#video14){ref-type="other"}. (**D**) Time colour-coded projection of gliding assay showing a microtubule bundle (arrow, appears white due to averaging of all time points) and individual microtubules over 447 s in the presence of 80 nM oMAP4. (**E**) Instantaneous speeds of microtubule motility were determined from tracks of 20 single and bundled microtubules and shown as histograms. (**F**) Time between start of observation and either end of observation or time when bundle was separated by motor forces. Bundles that moved out of the field or dissociated as intact bundle were not scored.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.035](10.7554/eLife.05697.035)Video 14.Microtubule gliding assay on a kinesin-1-coated surface in the presence of 80 nM GFP-oMAP4.Note that single microtubules move persistently, while bundles don\'t until they are driven apart. Scale bar: 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.036](10.7554/eLife.05697.036)10.7554/eLife.05697.036

Discussion {#s3}
==========

Why is a highly organised microtubule cytoskeleton required to undergo muscle differentiation? Microtubules are the stiffest of the cytoskeletal polymers that can bear high-compressive loads, especially when reinforced laterally ([@bib7]). Our data support a model in which microtubules fulfil a structural role during the elongation of muscle cells. If so, one would expect that the degree of alignment of microtubules will correlate with a cell\'s ability to elongate. We tested this by plotting the Kuiper statistic as a measure of microtubule orderliness against the mean cell length of 48 hr differentiated cells for different RNAi treatments used in this study and found indeed a linear correlation ([Figure 8A](#fig8){ref-type="fig"}). Likewise, the depletion of mMAP4, which increases the length of differentiating myoblasts also increases the paraxial microtubule alignment beyond that of control cells ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). These data support the idea that MT orientation is strongly linked to the morphological changes required for muscle differentiation. As observed for oMAP4, our previously published data on EB3 depletion ([@bib52]) and a number of unpublished observations, myoblasts that fail to elongate are also impaired in cell--cell fusion. While we don\'t yet understand the relationship between cell elongation and fusion, a mechanism to prevent the fusion of myoblasts that did not complete the previous step of differentiation, makes intuitively sense. oMAP4-depleted cells show in addition to impaired morphological changes, also a delay in the expression of myogenic markers, such as myogenin and embryonic myosin, further suggesting that a signalling step in the differentiation programme has not been completed. Microtubules have been implicated in a signalling role during myogenesis based on the observation that altering the level of posttranslational tubulin modifications either through chemical inhibition or depletion of microtubule-stabilising MAPs leads to similar delays in the expression of differentiation markers and impaired formation of myotubes ([@bib49]; [@bib10]; [@bib64]). The depletion of oMAP4 does not negatively affect tubulin acetylation ([Figure 3F](#fig3){ref-type="fig"}) but might impact other aspects of this putative microtubule-dependent signalling event. It will be a future challenge to elucidate the pathway that couples microtubule organisation and chemical modification to the timing of the myogenic protein expression programme.10.7554/eLife.05697.037Figure 8.oMAP4 and dynein co-operate in the organisation of the paraxial microtubule network in differentiating muscle cells.(**A**) Kuiper statistics of traced microtubule filaments as in [Figures 3G, 4](#fig3 fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} as a measure for microtubule orderliness is plotted against the mean cell length of 48 hr differentiated C2C12 myoblasts treated with shRNAs as indicated. A linear fit to the data is shown. (**B**) We propose that the correlation between the precision of paraxial alignment and cell elongation suggests that ordered microtubule arrays confer higher mechanical stability to counteract contractile forces. (**C**) Model of cooperation of oMAP4-mediated zippering with motor-driven microtubule sliding/transport in the formation of a highly ordered paraxial microtubule network. Microtubules are indicated in green, oMAP4 in magenta, dynein in blue, and kinesin in purple.**DOI:** [http://dx.doi.org/10.7554/eLife.05697.037](10.7554/eLife.05697.037)

We show that oMAP4 and PRC1 are both microtubule-bundling proteins, but with very different properties. While PRC1 is an antiparallel dimer that forms ordered crosslinks of a defined distance and specifically enriches in antiparallel-microtubule overlaps ([@bib5]; [@bib53]), oMAP4 has little preference for binding to bundles, but instead is able to zipper microtubules. Zippering of microtubules growing from surface-attached seeds requires bending of microtubules. We consider that the lateral forces required to bring two microtubules close together against the rigidity of the microtubule have to be borne by a single crosslinking molecule. Thus, our data suggest that single molecules of oMAP4 can resist higher loads than PRC1 crosslinks. When we apply longitudinal forces as experienced by pre-formed bundles in kinesin-gliding assays, the shear forces are probably shared between several crosslinking molecules, thus enabling oMAP4 to withstand counteracting motor forces on the bundled microtubules. Bundles that contain one very long microtubule that is driven laterally on the kinesin surface, eventually splay apart as lateral forces cannot be shared between the crosslinkers. In contrast, PRC1 cannot resist motor forces and at moderate levels only slightly slows motor-driven sliding of microtubules ([@bib5]; [@bib53]). Thus, oMAP4 has the required properties to fulfil the role of a microtubule organiser, justifying its name as organising MAP4, although the structural basis for oMAP4\'s antiparallel zippering remains to be elucidated.

The motors dynein and kinesin move microtubules and cause apparent disorder that is limited by oMAP4 crosslinking. However, both motors have also been reported to bundle and organise microtubules. Indeed, dynein depletion alone results in reduced microtubule alignment ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). This is consistent with the finding that dynein controls muscle length in *Drosophila* ([@bib17]) and earlier reports of dynein involvement in the self-organisation of microtubule networks and its ability to crosslink and slide antiparallel microtubules as well as transporting microtubules along the cell cortex ([@bib24]; [@bib1]; [@bib37]; [@bib15]; [@bib48]; [@bib54]). As oMAP4 is only able to efficiently zipper microtubules at incident angles of less than 30° if antiparallel and less than 10° if parallel, we propose that dynein-mediated looping and buckling of microtubules ([Figure 4E](#fig4){ref-type="fig"}; [@bib15]; [@bib54]) brings microtubules into a favourable position for oMAP4-mediated zippering. As oMAP4-mediated bundling resists motor-driven sliding, dynein can only move those microtubules that are not yet aligned to the paraxial network. Thus, dynein and oMAP4 are likely to cooperate in the formation of the highly ordered microtubule arrangement in differentiating muscle cells ([Figure 8C](#fig8){ref-type="fig"}). In the absence of oMAP4, excessive motor-driven microtubule motility disorganises microtubules. In the absence of dynein, oMAP4 might stabilise high-angle microtubule crossovers, but will not be able to align them into the network. If the activity of both oMAP4 and dynein is reduced, oMAP4 zippering is missing and kinesin-mediated sliding and bundling ([@bib51]; [@bib29]) prevails ([Figure 8B](#fig8){ref-type="fig"}). In agreement with this model, some disorganisation of microtubules has been observed in kinesin-1-depleted myotubes ([@bib63]). Microtubule--microtubule sliding has recently been implicated in driving neurite outgrowth ([@bib33]), and paraxial microtubule arrangements have been shown to drive dorsal closure during embryonic development ([@bib27]). Thus, the mechanisms we reveal here for motor and MAP cooperation in the formation of paraxial microtubule networks are likely to be of importance beyond muscle cells. Indeed, oMAP4 is highly expressed in brain ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}), suggesting that it might be required to support the paraxial microtubule arrays in dendrites and the axon.

While the zippering model described above explains how a paraxial array is maintained in the presence of microtubule turnover, it does not explain how the symmetry of the radial microtubule cytoskeleton in the myoblast is broken in the first place. We think that a bipolar elongating myoblast can be compared to a migrating cell with two fronts. Symmetry breaking in cell migration occurs through protrusion mediated by the actin cytoskeleton. Microtubules support and stabilise cell protrusions, and microtubule plus ends are selectively stabilised at the leading edge ([@bib61]; [@bib31]). This establishes and reinforces the new polarity axis. Similarly, in differentiating myoblasts dynamic capture of microtubule plus ends occurs at the cell tips ([@bib52]). This leads to the selective stabilisation of paraxial microtubules to break the symmetry in the microtubule network. The zippering mechanism described here would promote shorter microtubules to align to longer and already bundled microtubules and thus amplify the directional bias and increase stability and orderliness in the paraxial array. It is likely that the guidance of microtubule growth through the cooperation of plus end tracking proteins and motors also contributes to maintenance of the ordered array ([@bib35]). It will be interesting to dissect the contributions of these different pathways to microtubule network reorganisation, not only at the onset of myogenesis, but also during later stages when the parallel network is replaced by the grid-like lattice found in adult muscle ([@bib41]).

Materials and methods {#s4}
=====================

RNA extraction, cDNA preparation, and gene expression analyses {#s4-1}
--------------------------------------------------------------

RNA was extracted from 0 to 60 hr differentiated C2C12 cells using Trizol reagent (Invitrogen, Life Technologies, UK), and random-primed cDNA was synthesized using RevertAid H Minus M-MuLV Reverse Transcriptase (Fermentas, Fisher Scientific, UK) according to manufacturer\'s protocol. PCR reactions were carried out using cDNA timecourse samples as templates, isoform-specific upstream primers GCCAGCCTTCTGAGCCTTG (for uMAP4), GAGATCCAAGATGTTCAAGTC (for mMAP4), and CTGTTGGAAGAGACCCCAC (for oMAP4) and downstream primers CAGCTGGCACTGAGCCTG (to determine relative expression levels) and GAAGGGCCTCACTGCCAC (to determine number of microtubule binding repeats). As control, the coding sequence of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was amplified using the primers CCCACTTGAAGGGTGGAG and CAGGCGGCACGTCAGATC.

For differential expression analyses of MAP4 isoforms, the mouse genome assembly (release date July 2007 (NCBI37/mm9)) was examined using the UCSC Genome Browser at <http://genome.ucsc.edu/>. For RNA sequencing analyses, raw data from previously described C2C12 data sets ([@bib58], see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}) of the Mouse ENCODE project were exported. Reads per million (RPM) values were then summed and divided by the length of sequenced regions to obtain RPM/Kb values. Expression levels of MAP4 isoforms in various tissues were compared by exporting and analysing published Affymetrix mouse exon array data sets ([@bib44], see [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}) from the Genome Browser.

Cloning of MAP4 isoforms, shRNA plasmids, mammalian and bacterial expression constructs {#s4-2}
---------------------------------------------------------------------------------------

For cloning uMAP4 (accession number M72414) and oMAP4 (accession number BC042645), cDNA was amplified using primers CAGGTCGACAGAATGGCCGACCTCAG and GACCGCGGACGAGACCAGAATGTCATC for uMAP4, and GAGGTCGACATGGACTCCCGGAAAGAAATC and CCCGCGGTCTCAATTTGTCTCCTGG for oMAP4. PCR products were cloned into the MscI site of pCAP^s^ (Roche, UK) and confirmed by sequencing, digested with SalI and SacII, and transferred into pEGFP-C1 (Clontech, France). To clone mMAP4 (assembled from sequences under accession numbers M72414 and U08819), two overlapping fragments encoding its N-terminal and C-terminal domains were generated by PCR using primers CAGGTCGACAGAATGGCCGACCTCAG and CTGCAATCAGCAAGCCCAC, and CCTCTGGGAGATCACCATC and CCCGCGGTCTCAATTTGTCTCCTGG, respectively, and each cloned into pCAP^s^ and sequenced. Plasmids carrying N-terminal and C-terminal coding sequences were then digested with SalI + SpeI and SpeI + SacII, respectively, and cloned into the SalI + SacII sites of pEGFP-C1. To clone FLAG-oMAP4, a 5X-FLAG tag (DYKDADLDKDDDDK) was amplified by PCR and digested with NgoMIV and SalI. It was then inserted into pEGFP-oMAP4 that was opened with AgeI and SalI, thereby replacing the eGFP ORF. FLAG-oMAP4^RIP^ was generated using FLAG-oMAP4 as a template and primers GAGGTCGACATGGACTCCCGGAAAGAAATC, CTCCTCGAGTTAAGCAGTTGGTACCTGAG, and CCCAGCTGTGAACTTGGTTGATAAGTACCCCTG in 3-step mutagenesis PCR.

Bacterial expression vector for N-terminally 6xHis-tagged oMAP4 was generated by SalI + MfeI digestion of pEGFP-oMAP4 (four MTB repeats) and insertion of the coding sequence into the XhoI + EcoRI sites of pRSET-A. N-terminally 6x-His-eGFP-tagged oMAP4 expression construct was cloned by transferring EGFP-oMAP4 with NcoI-MfeI from pEGFP-oMAP4 (five MTB repeats) into the NcoI-EcoRI sites of pRSET-B vector (Invitrogen).

To clone GST fusions of MAP4 fragments for polyclonal antibody generation, regions specific to mMAP4 (amino acids 631--1060) and oMAP4 (amino acids 22--350) were obtained by PCR using pEGFP-mMAP4 (primers GCCAGCCTTCTGAGCCTTG and CTCCTCGAGTTAAGTAATGGCCCCTGGTTG) and pEGFP-oMAP4 (primers GAGGGTCAATTGAATGAAATCGGGCTGAATG and CTCCTCGAGTTAAGCAGTTGGTACCTGAG). mMAP4 and oMAP4 PCR products were then digested with EcoRI + XhoI and MfeI + XhoI, respectively, and inserted into the EcoRI + XhoI sites pGEX-6P-1 vector (GE Healthcare, UK).

Depletion constructs were based on pSUPERneo.gfp (Oligoengine, Seattle, WA). shRNA-target sequences were chosen using Oligo Retriever (<http://cancan.cshl.edu/RNAi_central/RNAi.cgi?type=shRNA>) and were as follows: shControl (targeting Luciferase): CGTACGCGGAATACTTCGA; sh-uMAP4: GCCTTGCTCAGGAGTATCC; sh-mMAP4: CAGAGAGTTTGGATAAGAA; sh-oMAP4: GCTGTGAATCTTGTCGATAAG; shDHC: CAATTACAGTCTGGAGTTA; shKHC (targeting Kif5b): CAATTGGAGTTATAGGAAA. The neo.gfp cassette was replaced by GFP-Tubulin, mCherry-Tubulin, or mEos2-Tubulin.

EB3-tdTomato, paGFP-Tubulin, and mEos2-Tubulin were described previously ([@bib46]; [@bib36]; [@bib48]).

Generation and purification of polyclonal antibodies {#s4-3}
----------------------------------------------------

Rabbit polyclonal antibodies against specific regions in oMAP4 and mMAP4 were raised against affinity purified GST-oMAP4~22--350~ and GST-mMAP4~631--1060~, respectively by Absea Biotechnology Ltd. (China). Polyclonal antibodies were purified from sera using the same GST fusion proteins. To do this, purified protein samples were run on SDS-PAGE, transferred to nitrocellulose membranes, protein bands were stained with Ponceau S and excised using a sterile scalpel. Membrane pieces were blocked with 5% wt/vol milk in TBST, cut into small pieces and incubated over night at 4°C in 1 ml TBST and 1 ml antiserum. Membrane pieces were washed thrice with TBST and antibodies were eluted by adding 200 μl 100 mM Glycine-HCl (pH 2.5) and vortexing for 1 min. Purified antibodies were then transferred to fresh tubes and neutralised immediately by adding 10 μl 1 M Tris-Base. Antibodies were stored at −20°C after adding Glycerol to a final concentration of 50% vol/vol.

Cell culture, plasmid transfections, and myoblast differentiation {#s4-4}
-----------------------------------------------------------------

Mouse C2C12 myoblasts were cultured on rat tail collagen (Sigma, UK) in DMEM-GlutaMAX (Invitrogen) supplemented with 10% fetal bovine serum (FBS), 2 mM L-Glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin with 5% CO~2~ in a humidified incubator. For localisation analyses, myoblasts were transfected with 1 μg plasmid DNA using Fugene 6 reagent (Roche) and analysed 48 hr post-transfection. For myoblast elongation and fusion analysis, 10,000 or 20,000 C2C12 cells, respectively, were seeded onto collagen-coated coverslips. Cells were transfected 24 hr later with a total amount of 1.5 μg shRNA constructs or shRNA and rescue constructs using Lipofectamine Plus reagent (Invitrogen) in OptiMEM (Invitrogen), which was replaced with growth medium 4--6 hr after transfection. Muscle cell differentiation was induced by replacing growth medium with differentiation medium (DMEM, 0.1% FBS, 2 mM L-glutamine, 5 μg/ml insulin, 5 μg/ml, transferrin, 100 U/ml penicillin and 100 μg/ml streptomycin) 20 hr after shRNA transfection. DMEM was changed daily and analysis of shRNA transfected cells was consistently performed 72--78 hr after transfection.

Live cell imaging and immunofluorescence experiments {#s4-5}
----------------------------------------------------

Live cells were imaged at 37°C and 5% CO~2~ in a stage top incubator (Tokai Hit, Fujinomiya, Japan) using a 100× or a 60× oil NA 1.4 objective on a Deltavision system (Applied Precision, LLC, Issaquah, WA) using Chroma filter sets and a Coolsnap HQ camera controlled by SoftWorx (Applied Precision, LLC). For all analysis of microtubule phenotypes, mono-nucleated, elongated cells were selected. For analyses of microtubule dynamics during myoblast differentiation, fluorescence images of EB3-tdTomato were acquired with 500 ms exposure at a temporal resolution of 3 s for 120 s. EB comets were tracked using plusTipTracker and further analysed for microtubule directionality using custom MATLAB code (see supplementary file MTdirectionality.m). For microtubule motility experiments, cells were transiently transfected with pSuper-mEOS2-Tubulin plasmids or co-transfected with paGFP-Tubulin and pSuper-mCherry-Tubulin plasmids. The microtubule cytoskeleton was focussed and bar-shaped regions of interest perpendicular to the microtubule network were selected using the non-converted mEOS2-Tubulin or mCherry-Tubulin signal. After photoactivation or photoconversion of these regions of interest using 10% 406 nm with the Deltavision photokinetics module laser power, images were acquired with 500 ms exposure at a temporal resolution of 1.6 s per frame for 60 s or lower temporal resolution for up to 6 min. Images were deconvolved with low noise filtering method for 10 iterations using SoftWorx (Applied Precision, LLC). Microtubule motility events were scored when an activated fragment moved for more than 0.5 μm from its original location. The velocity of microtubule movements was determined as the average velocity during each motility event, which lasted on average 15--20 s. Directionality of microtubule motility was scored as paraxial if within 45° of the long axis of the cell. Looping microtubules were defined as those that underwent a directional change of more than 90° during the movement event. For analysis of the contribution of microtubule dynamics and motor-driven microtubule movement to microtubule loss from photoactivated regions, undifferentiated or 48 hr differentiated C2C12 cells expressing mEOS2-Tubulin were treated with either 10 μM Taxol (to suppress MT depolymerisation) or 5 mM azide in 1 mM 2-deoxyglucose (to suppress motor activity) or a mixture of Taxol and azide (as a control for photobleaching) for 30 min before imaging. Signal intensity of photoconverted regions at each time point recorded using ImageJ. After background subtraction, photobleaching correction and normalisation of fluorescence intensity, the half-life of signal dissipation was determined by fitting a single exponential curve to the fluorescence intensity data over time.

For immunofluorescence experiments, cells were fixed in −20°C cold methanol for 24--48 hr. Fixed cells were rehydrated by washing with PBS for 5 min and blocked with 0.5% BSA wt/vol in PBST for 5 min. Coverslips were then incubated with primary antibodies overnight at 4°C or for 4 hr at RT and secondary antibodies for 1 hr in 0.5% BSA wt/vol in PBST. To stain DNA, coverslips were incubated with 4′,6-Diamidino-2-phenylindole dihydrochloride (\#D9542; DAPI; Sigma) for 2 min. Coverslips were then mounted using Vectashield mounting medium (\#H-1000; Vector Labs, UK). Primary antibody dilutions were as follows: rabbit anti-mMAP4 (1:1000), rabbit anti-PCM-1 (1:500, [@bib12]), mouse anti-embryonic myosin (1:50; F1.652, DSHB, University of Iowa), mouse anti-α-tubulin (1:1000; DM1A, Sigma), mouse anti-acetylated tubulin (1:1000; 6-11B-1, Sigma), mouse anti-myogenin (1:50; F5D, Santa Cruz (Dallas, TX)). Alexa488-, Alexa594- or Alexa647-conjugated anti-mouse or anti-rabbit secondary antibodies (Molecular Probes, Life Technologies, UK) were used at 1:500 dilution. For myoblast elongation analysis, cells were imaged using a 20× objective on the Deltavision system as above. Cell lengths of GFP-Tubulin-positive mono-nucleated cells were measured as straight-line distance from tip-to-tip using Image-Pro Analyzer 7.0 (Media Cybernetics, UK). For cell fusion analysis, cells with two or less nuclei (visualised as holes in GFP-Tubulin signal) and those with 3 or more nuclei were counted on the entire coverslip directly on the Deltavision microscope using a 20× objective and GFP filter sets. To analyse microtubule filament arrangement, GFP-Tubulin was imaged on a Perkin--Elmer UltraView spinning disk confocal system using a 488 nm laser and an Orca-R2 camera (Hamamatsu, Japan) under the control of Volocity software (Perkin--Elmer, Waltham, MA). Filaments were manually traced using ImageJ and deviation from the longitudinal cell axis calculated in MATLAB. To determine the number of bundles per cell, undifferentiated C2C12 cells were transiently transfected with either GFP-oMAP4 or GFP-uMAP4, fixed after 24 hr and stained with tubulin antibodies. Bundles were scored when elongated regions of more than 2.3-μm length had an intensity of more than threefold of a single microtubule. Superresolution images of microtubules labelled with anti-tubulin and Alexa488-conjugated anti-mouse antibodies and embedded in ProLong Gold reagent (Molecular Probes) were obtained on a N-SIM system (Nikon, Japan) at The Babraham Institute using 3D SIM mode with 15 individual images collected for reconstruction.

Immunoblotting {#s4-6}
--------------

For validation of depletion, shRNA-transfected and 52--54 hr differentiated cells were detached from culture dishes with Trypsin- EDTA. Trypsinised cells were then transferred to PBS +2% FBS and GFP expressing cells were sorted on FACSDiva or Influx instruments (BD Biosciences, UK). Collected cells were gently pelleted at 300×*g* for 2 min, resuspended to 10,000 cells/μl in 1× sample buffer and incubated at 95°C for 5 min. Immunoblotting was performed as described previously ([@bib48]). Primary antibody dilutions were as follows: mouse anti-α-tubulin (1:10,000; DM1A, Sigma), mouse anti-FLAG (1:5000; FLAG-M2, Sigma), mouse anti-DHC (1:500; R-325, Santa Cruz), mouse anti-uKHC (1:750; H-50, Santa Cruz), rabbit anti-uMAP4 (1:1,000, H-300, Santa Cruz), rabbit anti-mMAP4 (1:5000), rabbit anti-oMAP4 (1:5000), mouse anti-pentahis (1:3000, Qiagen (UK)). Horseradish peroxidase conjugated anti-mouse or anti-rabbit secondary antibodies (Promega, UK) were used at 1:4000 dilution.

Protein purification and glycerol gradients {#s4-7}
-------------------------------------------

6xHis-oMAP4 and 6xHis-GFP-oMAP4 were expressed in *E. coli* strain BL21-CodonPlus-(DE3) and expression was induced with 0.5 mM isopropyl-β-D-thiogalactoside at 37°C. Bacteria were lysed in binding buffer (50 mM NaPO~4~ buffer, pH 8.0; 300 mM NaCl; 2 mM β-mercaptoethanol; 15% glycerol) by sonication. oMAP4 was bound to Ni-NTA resin (Qiagen) and eluted with 250 mM imidazole in binding buffer. After twofold dilution with low-salt buffer (20 mM MES, pH 6.8; 1 mM EGTA; 0.5 mM MgCl~2~) the MAP4-containing fractions were loaded on SP Fast Flow Sepharose (GE Healthcare), washed with low-salt buffer and eluted with a step gradient of high-salt buffer (20 mM MES, pH 6.8; 1 mM EGTA; 0.5 mM MgCl~2~; 1 M NaCl). All purification was carried out at room temperature to minimise protein aggregation. Proteins were analysed by SDS--polyacrylamide gel electrophoresis and SimplyBlue staining (Invitrogen). Buffer exchange to BRB80 (80 mM PIPES, pH 6.8; 1 mM MgCl~2~; 1 mM EGTA) was carried out using Vivaspin spin columns (Sartorius, Germany) according to the manufacturer\'s protocol. GST fusion proteins for antibody generation and purification were bound to Glutathione-Agarose (Sigma), washed with PBS and eluted with GST elution buffer (50 mM Tris-HCl, pH-8.0; 150 mM NaCl; 2 mM 2-Mercaptoethanol; 10 mM Glutathione). Full-length *Drosphila* kinesin-1 was purified previously ([@bib8]). EB1-GFP-6xHis was purified as described previously ([@bib21]). 6xHis-PRC1 was purified using Ni-NTA as described for 6xHis-oMAP4 above.

To determine sedimentation properties, cleared extracts of BL21 cells expressing 6xHis-oMAP4 and 6xHis-GFP-oMAP4 in BRB80 plus complete protease inhibotors (Roche) were loaded onto 5-ml 10--40% vol/vol glycerol gradients prepared with a Gradient Master (Biocomp, Canada) and spun at 45,000×*g* in a SW55Ti rotor for 14 hr. Standard proteins were loaded at 5 mg/ml individually on separate gradients. Gradients were fractionated by pipetting from the top in 250 μl aliquots and analysed by measuring the absorbance at 280 nm or analysing band intensity on coomassie-stained polyacrylamide gels or immunoblots using pentahis antibodies (Qiagen). The frictional ratio was determined *ƒ/ƒ*~*min*~ = *S*~*max*~*/S* with *S*~*max*~ = 0.00361·*M*^*2/3*^ in Svedbergs for a protein of mass *M* in Daltons ([@bib14]).

In vitro microtubule zippering and kinesin gliding assays {#s4-8}
---------------------------------------------------------

Tubulin was prepared from pig brains according to published protocols ([@bib20]). Labelled tubulin was from Cytoskleleton Inc. (Denver, CO), nucleotides were from Jena Biosciences (Germany) and all other chemicals were from Sigma unless indicated. Microtubule seeds were assembled from tubulin, biotin-tubulin, and Hilyte647-tubulin at a molar ratio of 25:1:2 in the presence of 1 mM GMP-CPP in MRB80 (80 mM PIPES, pH 6.8 with KOH, 1 mM EGTA, 4 mM MgCl~2~) for 1 hr at 37°C, diluted 20-fold with MRB80 + 2 μM Paclitaxel and stored at RT. A 100-μm deep flow chamber was made from a slide and a hydrochloric acid-treated coverslip using double-sided tape (Scotch 3M, UK). For MT dynamics assays, the flow chamber was passivated with PLL-PEG-50% biotin (Susos AG, Zurich, Switzerland). Seeds were attached to this surface using streptavidin and blocked with 1 mg/ml κ-casein. A reaction mix containing 15 μM tubulin, 1 μM X-Rhodamine tubulin, 50 mM KCl, 1 mM GTP, 0.6 mg/ml κ-casein, 0.2% methyl cellulose, 4 mM DTT, 0.2 mg/ml catalase, 0.4 mg/ml glucose oxidase, 50 mM glucose in MRB80, supplemented with 80 nM GFP-oMAP4 or buffer was clarified for 8 min at 190,000×*g* in an airfuge (Beckman Coulter, UK), the supernatant added to the flow chamber and sealed with candle wax. For gliding assays, 3 nM *Drosophila* kinesin in MRB80, supplemented with 10 mM β-Mercaptoethanol and 0.1 mM MgATP were flown into the glass chamber, before blocking with 1 mg/ml κ-casein. The gliding mix containing X-rhodamine- and Hilyte647-labelled microtubules, 1 mM ATP, 4 mM MgCl~2~, oxygen scavenger system (4 mM DTT, 0.2 mg/ml catalase, 0.4 mg/ml glucose oxidase, 50 mM glucose), ATP regeneration system (5 mM phosphocreatine, 7 U/ml creatine phosphokinase), 80 nM GFP-oMAP4 in MRB80 was added to the flow chamber and sealed with candle wax. Microtubule assembly and gliding assays were observed on an Olympus TIRF system using a 100× NA 1.49 objective, 1.6× additional magnification, 488 nm, 561 nm, and 640 nm laser lines, a Hamamatsu ImageEM-1k back-illuminated EM-CCD camera under the control of xcellence software (Olympus, Germany). Microtubule gliding speeds were determined from tracks obtained using ImageJ plugin MTrackJ. Microtubule encounters were classified as zippering when they resulted in bundling for a minimum length of 2 μm away from the initial point of contact. For parallel bundling, zippering would need to occur towards the minus end of both microtubules. For antiparallel zippering, both aligned microtubule ends would need to continue growth for at least 2 μm along the lattice of the other microtubule. Microtubule lengths were measured to address whether the bias in microtubule zippering by oMAP4 arises from differences in lengths between parallel and antiparallel microtubules. For microtubule encounters in either orientation that resulted in successful zippering, distance from the point of encounter to the microtubule seed or to the next microtubule crossover point was measured. Microtubule lengths were measured similarly for unsuccessful encounters but these were restricted to shallow angle encounters at which oMAP4-mediated zippering typically occurs, that is, 10°--30°.

Microtubule pelleting and bundling assays {#s4-9}
-----------------------------------------

Microtubules were polymerised in BRB80 buffer from 40 to 50 μM pig-brain tubulin in the presence of 1 mM GTP by incubation at 37°C for 30 min and stabilised by addition of 20 μM Paclitaxel (Sigma). To remove non-polymerised tubulin, microtubules were pelleted by centrifugation at 45,000 RPM for 25 min at 27°C, washed with and resuspended in BRB80 and 20 μM Paclitaxel. To test binding of MAP4 proteins to microtubules, 1.5 μM of Taxol-stabilised microtubules was mixed with purified 60 nM oMAP4 in the presence of 20 μM Paclitaxel in BRB80 in a total volume of 50 μl. Reactions were then incubated for 20 min at 37°C and centrifuged at 35°C, 50,000 RPM for 15 min. After recovery of the supernatant, the pellet was washed with and then resuspended in 50 μl BRB80 and 20 μM Paclitaxel. After addition of SDS-PAGE sample buffer, pellet and supernatant fractions were analysed by SDS-PAGE. For microtubule bundling experiments, 40 μl drops of 0.1 mg/ml Poly-L-Lysine (Sigma) were placed onto 70% ethanol washed and air-dried 22 × 22 mm glass coverslips (Menzel-Gläser, Germany). After removal of the Poly-L-Lysine solution using a bench top coverslip centrifuge (Technical Video Ltd., Port Townsend, WA), coverslips were rinsed three times with 150 μl ddH~2~O using the same procedure and air dried. To test if oMAP4 can bundle microtubules, Rhodamine-labelled microtubule seeds stabilised with GMP-CPP or Taxol-stabilised microtubules were mixed in BRB80 in a total volume of 10 μl and incubated with buffer or with 60 nM oMAP4 at 22°C for 10--15 min. 1 μl samples of reactions were then placed onto slides, mounted with Poly-L-Lysine coated coverslips, and imaged using the Deltavision widefield system as above. For comparative analysis of EB1-, PRC1-, and oMAP4-mediated bundling, freshly polymerised GMPCPP-stabilised Hilyte647-labelled microtubules were incubated with 80 nM protein in MRB80 for 10 min before loading into a 10 μm flow chamber made from a slide and a poly-lysine-coated coverslip. At least 30 random fields were imaged using TIRF microscopy at critical angle. Bundles were counted if at least three times as bright as single microtubules.

Statistical data analysis {#s4-10}
-------------------------

Statistical data analyses and graphing were performed using Origin Pro 8.5 (OriginLab, Northampton, MA) or MATLAB (Mathworks, Natick, MA). Image preparation for publication was done using deconvolution in Softworx (Applied Precision), ImageJ and Adobe Illustrator. All statistical significance analyses were carried out using two-tailed two-sample t-tests assuming equal variance. Kuiper statistics was calculated from cumulative distributions of data compared to a random distribution using custom MATLAB code (see [Source code 1](#SD3-data){ref-type="supplementary-material"} MTdirectionality.m).
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10.7554/eLife.05697.038

###### 

RNAseq_Myoblast_Myocyte. RNA sequencing data for C2C12 myoblasts and 60 hr differentiated myocytes ([@bib58]) extracted for four regions in MAP4 as shown in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.

**DOI:** [http://dx.doi.org/10.7554/eLife.05697.038](10.7554/eLife.05697.038)

10.7554/eLife.05697.039

###### 

Affymetrix Exon Arrays. Affymetrix exon array data ([@bib44]) for four regions in MAP4 as shown in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}.

**DOI:** [http://dx.doi.org/10.7554/eLife.05697.039](10.7554/eLife.05697.039)

10.7554/eLife.05697.040

###### 

MATLAB code MTdirectionality. Custom MATLAB function to compute directionality of MT growth relative to the main cell axis, generate figure with tracks colour-coded for direction, plot angular histograms and calculate Kuiper statistics relative to a random distribution.

**DOI:** [http://dx.doi.org/10.7554/eLife.05697.040](10.7554/eLife.05697.040)

Major datasets {#s6-1}
--------------

The following previously published datasets were used:

Pohl A, Smith K, Fujita P, Cline M, Sugnet C, 2009,Affy Exon Tissues,[http://genome-euro.ucsc.edu/cgi-bin/hgTrackUi?hgsid=208289381_jS9DPWNm4JLAAK3Cg8Wwjs2MvakG&g=affyExonTissues](http://genome-euro.ucsc.edu/cgi-bin/hgTrackUi?hgsid=208289381_jS9DPWNm4JLAAK3Cg8Wwjs2MvakG%26g=affyExonTissues),Publicly available as tracks in UCSC Genome Bioinformatics.

Williams B, Marinov G, Trout D, Schaeffer L, Kwan G, Fisher K, De Salvo G, Mortazavi A, Amrhein H, King B, 2012,Caltech RNA-seq Track,[http://genome.ucsc.edu/cgi-bin/hgTrackUi?g=wgEncodeCaltechRnaSeq&hgsid=419817771_YnYIEb0JfLUWZhhJlY3MSCt32Ok9](http://genome.ucsc.edu/cgi-bin/hgTrackUi?g=wgEncodeCaltechRnaSeq%26hgsid=419817771_YnYIEb0JfLUWZhhJlY3MSCt32Ok9),Publicly available as tracks in UCSC Genome Bioinformatics.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "A novel isoform of MAP4 organises the antiparallel microtubule array required for muscle cell differentiation" for consideration at *eLife*. Your article has been favorably evaluated by Vivek Malhotra (Senior editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

1\) The in vitro experiments require additional controls and quantification:

1A) There is a huge difference in electrophoretic mobility between the endogenous oMAP4 and the recombinant protein used for reconstitution experiments. The validity of the in vitro reconstitution relies completely on the quality of the protein used, so this point requires clarification.

1B) A negative and a positive control for the formation of microtubule bundles should be shown. The negative control would be a protein that does not create microtubule bundles (for example, kinesin-1 motor domain, EB1 or another microtubule-binding protein which does not function as a microtubule-bundling factor in cells). This would be used to exclude artifactual sources of bundling in the assay (e.g., protein misfolding). The positive control would be an established microtubule bundler, such as PRC1. A comparison with an established anti-parallel bundler is important because the provided data do not conclusively prove that oMAP4 a "true" antiparallel bundler (a protein, whose structure dictates a preference for binding to antiparallel microtubule overlaps). The alternative is that oMAP4 creates randomly-oriented bundles with microtubules pointing in both directions. Such bundles would also resist gliding by kinesin motors and splay apart, as shown in [Figure 7](#fig7){ref-type="fig"}. To create a random bundle, oMAP4 would need to zipper both parallel and antiparallel overlaps. [Figure 6B](#fig6){ref-type="fig"} shows that zippering occurs with higher frequency when the microtubules grow towards each other at ∼180 degrees. This higher frequency is the only evidence that oMAP4 has a structural preference for antiparallel overlaps. But there might be explanations other than structural preference: for example microtubules may be longer when they encounter each other at ∼180 degrees, and longer microtubules zipper more easily. In this context a positive control would be very useful. What does [Figure 6B](#fig6){ref-type="fig"} look like for PRC1, for example? This is an essential point, because random bundles and structured, antiparallel bundles have different implications for the structure of oMAP4, for its cellular function and the model in [Figure 8](#fig8){ref-type="fig"}. The microtubule-binding domain of MAP4 alone could be another optional control.

1C) The data shown in [Figure 5C, D](#fig5){ref-type="fig"} (loops and bundles in vitro) should be quantified: for example, the length of bundled microtubules, the frequency of looping, or some other objective measure could be determined and compared to a positive and negative control.

2\) Experiments in cells require some additional analyses and explanation:

2A) Images and quantification of microtubule organization in cells depleted of mMAP4 and uMAP4, as well as in rescue experiments with the oMAP4 isoform should be included in [Figure 3](#fig3){ref-type="fig"} (now these controls and rescue are only shown for the fusion phenotype, but it is not even clear how exactly the fusion phenotype relates to the microtubule organization). Further, the quality of microtubule images in [Figure 3](#fig3){ref-type="fig"} is less good than in [Figure 1](#fig1){ref-type="fig"}, so the microtubule tracing is less convincing. It would be good to improve this, especially if the authors have access to structured illumination microscopy. Some quantification of the extent of microtubule bundling in different RNAi conditions, if possible, would also be useful.

2B) The authors should provide a better description and some explanation of the differences in the expression of embryonic myosin and relocalization of PCM-1. How can these phenotypes be caused by microtubule disorganization? A better discussion would seem appropriate. Likewise, it is not clear how the reduction of the expression in embryonic myosin follows from the provided images, and how this might be connected to the geometry of microtubule arrays. Again, some additional discussion would help. It would also be helpful if the authors explained what "myogenin" is so that a reader does not have to look it up.

3\) Other comments:

3A) The expression of oMAP4 in real muscles should be addressed at least by review of database data, because gene expression in a particular cell line does not necessarily reflect the in vivo situation.

3B) In the Discussion, the authors write: "Thus the mechanisms we reveal here for motor and MAP cooperation in the formation of antiparallel microtubule networks are likely to be of importance beyond muscle cells" but do not expound further. This point gets at the potential impact of this work and its appropriateness for *eLife*, a journal meant to appeal to broad audiences. The appeal could be broadened by describing exactly how these mechanisms are important beyond muscle cells, comparing/contrasting oMAP4 with other bundling proteins, and possibly by phrasing the paper in terms of general mechanisms of bundling. Here, the controls would help, because using a positive control will lead naturally to a comparison that places the work in a broader context.

3C) [Figure 8A, B](#fig8){ref-type="fig"} seems to belong in the Results and not in the Discussion. It would also be good if the authors provided some explanation of the fact that the double DHC+oMAP4 depletion has a weaker phenotype that the single ones.

3D) The authors should consider presenting some data as radial histograms, specifically [Figures 1C, 3H, and 3](#fig1 fig3){ref-type="fig"}. The point of the data will be clearer.

3E) An explanation for the "o" in oMAP4 would be helpful. Is the "o" for overlap?

3F) The authors give a *p*-value of something like 10\^-52. Saying *p*\<\<0.001 is the norm.

3G) There are no supplemental movies for the EB experiments (e.g., [Figure 3I](#fig3){ref-type="fig"}). These should be included.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled "A novel isoform of MAP4 organises the antiparallel microtubule array required for muscle cell differentiation" for further consideration at *eLife*. Your revised article has been favorably evaluated by Vivek Malhotra (Senior editor) and a member of the Board of Reviewing Editors. The manuscript has been improved but there are two remaining issues that need to be addressed before acceptance, as outlined below:

1\) The quality of the images in [Figure 3G](#fig3){ref-type="fig"} is rather poor. Since these data are crucial for your conclusions, we would like to ask you to include additional images and tracings for all conditions shown in [Figure 3--figure supplement 1 and 2](#fig3s1 fig3s2){ref-type="fig"}, so that the readers can judge for themselves whether they find the data reliable.

2\) The in vitro evidence on oMAP4 as an anti-parallel bundler is still not convincing. For the proposed function, it actually would make sense that oMAP4 can make both parallel and anti-parallel bundles. We would like to suggest you reformulate the Title and downplay the message about anti-parallel bundling in the Abstract.

10.7554/eLife.05697.042

Author response

*1) The in vitro experiments require additional controls and quantification*:

*1A) There is a huge difference in electrophoretic mobility between the endogenous oMAP4 and the recombinant protein used for reconstitution experiments. The validity of the in vitro reconstitution relies completely on the quality of the protein used, so this point requires clarification*.

Our recombinant protein runs at the correct size for its molecular weight when expressed and purified from *E.coli*. However, expressing the same protein in HeLa cells, causes an increase in apparent molecular weight and the native protein detected by specific antibodies in differentiating muscles cells runs even higher. As proteins are not subject to modifications when expressed recombinantly in bacteria and MAP4 could be subject to different modifications when expressed exogenously in HeLa cells, the observed differences are likely caused by posttranslational modifications. MAP4 is known to be subject to phosphorylation (Semenova et al., Mol Biol Cell 2014) and all MAP4 isoforms as well as other structural MAPs run well above their molecular weight on SDS-PAGE: uMAP4 (West et al., J Biol Chem 1991), mMAP4 (Mangan et al., Development 1996) and other structural MAPs (Noble et al., J Cell Biol 1989; Lee et al., Science 1988; Irminger-Finger et al., J Cell Biol. 1990). We have confirmed the identity of the purified protein using mass spectroscopy, peptides found covered 77% of the proteins with no substantial gaps. We are therefore confident that the protein expressed from our RNAi-resistant rescue constructs mediating oMAP4 function and the purified protein used for in vitro experiments are functionally equivalent.

*1B) A negative and a positive control for the formation of microtubule bundles should be shown. The negative control would be a protein that does not create microtubule bundles (for example, kinesin-1 motor domain, EB1 or another microtubule-binding protein which does not function as a microtubule-bundling factor in cells). This would be used to exclude artifactual sources of bundling in the assay (e.g., protein misfolding). The positive control would be an established microtubule bundler, such as PRC1. A comparison with an established anti-parallel bundler is important because the provided data do not conclusively prove that oMAP4 a "true" antiparallel bundler (a protein, whose structure dictates a preference for binding to antiparallel microtubule overlaps). The alternative is that oMAP4 creates randomly-oriented bundles with microtubules pointing in both directions. Such bundles would also resist gliding by kinesin motors and splay apart, as shown in* [*Figure 7*](#fig7){ref-type="fig"}*. To create a random bundle, oMAP4 would need to zipper both parallel and antiparallel overlaps.* [*Figure 6B*](#fig6){ref-type="fig"} *shows that zippering occurs with higher frequency when the microtubules grow towards each other at ∼180 degrees. This higher frequency is the only evidence that oMAP4 has a structural preference for antiparallel overlaps. But there might be explanations other than structural preference: for example microtubules may be longer when they encounter each other at ∼180 degrees, and longer microtubules zipper more easily. In this context a positive control would be very useful. What does* [*Figure 6B*](#fig6){ref-type="fig"} *look like for PRC1, for example? This is an essential point, because random bundles and structured, antiparallel bundles have different implications for the structure of oMAP4, for its cellular function and the model in* [*Figure 8*](#fig8){ref-type="fig"}*. The microtubule-binding domain of MAP4 alone could be another optional control*.

As requested we repeated both bundling free in solution and zippering experiments using EB1-GFP as a negative control and PRC1 as a positive control. The new data are shown in [Figure 5E-F](#fig5){ref-type="fig"} and [Figure 6B](#fig6){ref-type="fig"}. We found that PRC1 was a more efficient bundling protein for free microtubules, but failed to zipper surface attached microtubules. Therefore, we could not compare the antiparallel bias in zippering for PRC1 and oMAP4. Instead, we have followed the additional suggestion to determine the length dependence of zippering and did not find a significant difference between the length distributions of microtubules that are zippered by oMAP4, fail to be zippered, are of parallel or antiparallel orientation. These data are included in the new [Figure 6--figure supplement 1](#fig6s1){ref-type="fig"}. Thus our data show that oMAP4 more efficiently zippers antiparallel microtubules, but can also zipper parallel microtubules. We do think that zippering in either orientation supports an ordered paraxial array and there is no requirement for a preference for its cellular function.

*1C) The data shown in* [*Figure 5C, D*](#fig5){ref-type="fig"} *(loops and bundles in vitro) should be quantified: for example, the length of bundled microtubules, the frequency of looping, or some other objective measure could be determined and compared to a positive and negative control*.

As mentioned in response to 1B above, we have repeated these experiments, included PRC1 and EB1 as controls and quantified the occurrence of microtubule bundles formed in solution. The new data are shown in [Figure 5E-F](#fig5){ref-type="fig"}.

*2) Experiments in cells require some additional analyses and explanation*:

*2A) Images and quantification of microtubule organization in cells depleted of mMAP4 and uMAP4, as well as in rescue experiments with the oMAP4 isoform should be included in* [*Figure 3*](#fig3){ref-type="fig"} *(now these controls and rescue are only shown for the fusion phenotype, but it is not even clear how exactly the fusion phenotype relates to the microtubule organization). Further, the quality of microtubule images in* [*Figure 3*](#fig3){ref-type="fig"} *is less good than in* [*Figure 1*](#fig1){ref-type="fig"}*, so the microtubule tracing is less convincing. It would be good to improve this, especially if the authors have access to structured illumination microscopy. Some quantification of the extent of microtubule bundling in different RNAi conditions, if possible, would also be useful*.

We have performed the requested additional experiments and determined microtubule orientation for uMAP4 and mMAP4 depletion as well as for the oMAP4 rescue experiment. The new data are shown in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}. Unfortunately we have no regular access to superresolution microscopy and performed the new experiments identically to the previously existing data from spinning disk images. While it is not possible to trace every single microtubule, we believe the assay is valid and robust as it is reproducible even if different individuals blind to the expected result manually segment microtubules. The density of microtubules in differentiating cells precludes a meaningful analysis of bundling with light microscopy methods.

*2B) The authors should provide a better description and some explanation of the differences in the expression of embryonic myosin and relocalization of PCM-1. How can these phenotypes be caused by microtubule disorganization? A better discussion would seem appropriate. Likewise, it is not clear how the reduction of the expression in embryonic myosin follows from the provided images, and how this might be connected to the geometry of microtubule arrays. Again, some additional discussion would help. It would also be helpful if the authors explained what "myogenin" is so that a reader does not have to look it up*.

We have added a paragraph to the Discussion (first paragraph) that elaborates on this issue, but we cannot do much more than speculate at this point as substantially more research in this area is required to understand the relationship between microtubule organisation, chemical modifications and the myogenic programme. We have added a note to the figure legend explaining that myogenin is used here as a marker for differentiating myoblasts.

*3) Other comments*:

*3A) The expression of oMAP4 in real muscles should be addressed at least by review of database data, because gene expression in a particular cell line does not necessarily reflect the in vivo situation*.

We added a new [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"} showing RNA sequencing and tissue microarray data that (1) verify our data regarding differential expressing in C2C12 myoblasts and differentiated myocytes and (2) show the expression profile of all MAP4 isoforms in different tissues. oMAP4 is highly expressed in brain and skeletal muscle, while mMAP4 is most prevalent in skeletal muscle and heart. The ubiquitous uMAP4 shows little differential expression.

*3B) In the Discussion, the authors write: "Thus the mechanisms we reveal here for motor and MAP cooperation in the formation of antiparallel microtubule networks are likely to be of importance beyond muscle cells" but do not expound further. This point gets at the potential impact of this work and its appropriateness for* eLife*, a journal meant to appeal to broad audiences. The appeal could be broadened by describing exactly how these mechanisms are important beyond muscle cells, comparing/contrasting oMAP4 with other bundling proteins, and possibly by phrasing the paper in terms of general mechanisms of bundling. Here, the controls would help, because using a positive control will lead naturally to a comparison that places the work in a broader context*.

The additional data showing expression of oMAP4 in brain suggest an importance for oMAP4 in organising the non-centrosomal microtubules in axon and dendrites that remains to be confirmed. MAP4 has so far been considered as the non-neuronal tau equivalent and its role in the presence of the other members of the structural MAP family remain to be elucidated. Further, our additional in vitro experiment show differences in the properties of PRC1 and oMAP4, prompting a number of open questions to understand the structural basis of the ability to zipper microtubules and the directional bias in crosslinking by a largely unstructured protein. We now explain this is the Discussion section.

*3C)* [*Figure 8A, B*](#fig8){ref-type="fig"} *seems to belong in the Results and not in the Discussion. It would also be good if the authors provided some explanation of the fact that the double DHC+oMAP4 depletion has a weaker phenotype that the single ones*.

Our model in [Figure 8C](#fig8){ref-type="fig"} and described in the Discussion offers a possible explanation why co-depletion of dynein alleviates microtubule alignment. As in many biological processes, imbalance probably causes the biggest problems and the removal of dynein that is responsible for looping movements and the crosslinker oMAP4 that prevents this, probably allows room for other proteins with crosslinking activity such as kinesin-1 and other organising activities such as guided microtubule assembly to dominate. We now moved the data from [Figure 8](#fig8){ref-type="fig"} into [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"} and mention them in the Results.

*3D) The authors should consider presenting some data as radial histograms, specifically* [*Figures 1C, 3H, and 3*](#fig1 fig3){ref-type="fig"}*. The point of the data will be clearer*.

As requested we have included radial histograms for the data shown in [Figure 1C](#fig1){ref-type="fig"} ([Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}), the new data obtained for uMAP4, mMAP4, oMAP4 depletion and oMAP4 rescue in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}, the data shown in [Figure 3J](#fig3){ref-type="fig"} ([Figure 3--figure supplement 2](#fig3s2){ref-type="fig"}) and the data shown in [Figure 3H](#fig3){ref-type="fig"} and previously shown in [Figure 8B](#fig8){ref-type="fig"} ([Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}).

3E) An explanation for the "o" in oMAP4 would be helpful. Is the "o" for overlap?

We of course named the third MAP4 isoform before we knew what it was doing and the true meaning is "other". However, we agree that this is not satisfactory and as oMAP4 is a microtubule organiser we have decided oMAP4 to stand for [o]{.ul}rganising microtubule-associated protein 4. We included a statement to this effect in the Discussion.

*3F) The authors give a* p*-value of something like 10\^-52. Saying* p*\<\<0.001 is the norm*.

We have amended this as suggested.

*3G) There are no supplemental movies for the EB experiments (e.g.,* [*Figure 3I*](#fig3){ref-type="fig"}*). These should be included*.

We have included the movies of the cells for which tracks are shown in [Figure 3I](#fig3){ref-type="fig"} as new [Movies 8 and 9](#video8 video9){ref-type="other"}.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*1) The quality of the images in* [*Figure 3G*](#fig3){ref-type="fig"} *is rather poor. Since these data are crucial for your conclusions, we would like to ask you to include additional images and tracings for all conditions shown in* [*Figure 3--figure supplement 1 and 2*](#fig3s1 fig3s2){ref-type="fig"}*, so that the readers can judge for themselves whether they find the data reliable*.

We added two examples with traces for each of the 5 conditions shown in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"} as suggested. [Figure 3--figure supplement 2](#fig3s2){ref-type="fig"} contains EB tracks for which an example is shown in [Figure 3I](#fig3){ref-type="fig"} and supplementary movies are provided. For the MT orientation data shown in [Figure 3G-H](#fig3){ref-type="fig"} and [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}, we now provide deconvolved images and movies and hope the quality is sufficiently improved to believe the accompanying traces. Note there are now three examples with traces for control and oMAP4 RNAi data, one each in [Figure 3G](#fig3){ref-type="fig"} and two each in [Figure 3--figure supplement 1](#fig3s1){ref-type="fig"}.

*2) The in vitro evidence on oMAP4 as an anti-parallel bundler is still not convincing. For the proposed function, it actually would make sense that oMAP4 can make both parallel and anti-parallel bundles. We would like to suggest you reformulate the Title and downplay the message about anti-parallel bundling in the Abstract*.

We exchanged the word antiparallel with paraxial in the Title and Abstract and throughout the manuscript text where it was more appropriate, i.e. referred to MTs in cells as this describes the arrangement more accurately. oMAP4 shows a bias for zippering antiparallel versus parallel microtubules. We feel we described this accurately in the manuscript, but there isn't sufficient space in the Abstract to include all detail, especially as we could only assess kinesin forces on antiparallel bundles.

[^1]: Department of Chemical and Biomolecular Engineering, University of Illinois, Champaign, United States.
